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1 General Experimental 
Unless otherwise specified, all reactions were carried out under Ar atmosphere in oven-dried 
glassware. 
Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled over sodium and benzophenone, 
triethylamine (NEt3) and N,N-diisopropylamine (DIPA) over calcium hydride. All other solvents as well 
as starting materials and reagents were obtained from commercial sources and used without further 
purification. 
Flash column chromatography was performed using the analytical grade solvents indicated and 
Merck silica gel (40–63 μm, 60 Å) as the stationary phase. Reactions and chromatography fractions 
were monitored with Merck silica gel 60 F254 glass plates and visualized using a 254 nm UV lamp 
and/or by treatment with a suitable dip (potassium permanganate, ceric ammonium molybdate or 
anisaldehyde) followed by heating. 
Proton (1H) and carbon (13C) NMR spectra were recorded at 23 °C (unless otherwise stated) on Bruker 
400 or Bruker Avance III 500 or Varian 600 instrument. The spectral analysis of crocagin A (1) and the 
mixed NMR experiments were performed with Bruker Avance III 700 spectrometer with a 5 mm TCI 
cryoprobe (1H 700 MHz, 13C 175 MHz). Chemical shifts (δ) are expressed in parts per million (ppm) 
and are calibrated using residual protic solvent as an internal reference for proton (CHCl3: δ = 7.26 
ppm, CH3OH: δ = 3.31 ppm, DMSO-d6: δ = 2.50 ppm), and for carbon the central carbon resonance of 
the solvent (CDCl3: δ = 77.16 ppm, CD3OD: δ = 49.00 ppm, DMSO-d6: δ = 39.52 ppm).
 
Multiplicity is 
defined as: s = singlet; d = doublet; t = triplet; q = quartet; m = multiplet, br = broad or combinations 
of the above. To assign proton and carbon spectra, a range of 2D-NMR experiments (COSY, HSQC, 
HMBC, NOESY) were used. The numbering of atoms in the molecules does not correspond to the 
IUPAC nomenclature. 
Infrared spectra were recorded on a Perkin-Elmer BXII-FTIR spectrometer. Samples were analyzed as 
neat materials. 
Mass spectrometry experiments were performed on a Thermo Finnigan MAT 95 (Electron Ionisation, 
EI) and on a Thermo Finnigan LTQ FT (Electrospray Ionisation, ESI) instrument. 
Melting points were measured on a Büchi melting point B-540 system and are uncorrected. 
Optical rotations were measured at the given temperature (T in [°C]) on a Perkin-Elmer 241 or Krüss 
P8000-T polarimeter using a sodium lamp (Na D-line, 589 nm). Measurements were carried out in a 
cell with path length (l) of 0.5 dm. Concentrations are given in g/100 mL  
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2 Experimental Procedures 
2.1 (R)-Methyl 2-(3-(4-(benzyloxy)phenyl)-3-oxopropanamido)-3-(1H-indol-3-
yl)propanoate (9) 
 
Diisopropylcarbodiimide (4.90 mL, 31.5 mmol; 1.5 eq) was added portionwise to a suspension of 
amine 7 (5.35 g; 21.0 mmol), β-ketoacid 8[1] (6.24 g; 23.1 mmol; 1.1 eq), HOBt (4.54 g; 33.6 mmol; 1.6 
eq) and triethylamine (6.50 mL; 46.2 mmol; 2.2 eq) in dry dichloromethane (135 mL). After stirring 
for 40 h, the reaction mixture was diluted with dichloromethane and washed with 1M HCl, saturated 
NaHCO3 and brine. The extract was dried over anhydrous Na2SO4, concentrated in vacuo and purified 
by flash chromatography (50% EtOAc/hexanes → 70% EtOAc/hexanes), to aﬀord 7.83 g (79%) of the 
pure β-ketoamide 9, as a yellowish foam. 
 
Rf = 0.20 (40% EtOAc in hexanes). 
[α]D
26 = −49.3° (c = 0.75, CHCl3).  
1
H NMR (600 MHz, CDCl3): δ 8.08 (s, 1H), 7.92 (d, J = 9.0, 2H), 7.53 (d, J = 8.0, 1H), 7.50 (d, J = 7.6, 
1H), 7.42 – 7.31 (m, 5H), 7.32 (d, J = 8.9, 1H), 7.18 – 7.13 (m, 1H), 7.10 – 7.05 (m, 1H), 7.03 (d, J = 2.4, 
1H), 7.00 (d, J = 9.0, 2H), 5.14 (s, 2H), 4.94 (dt, J1 = 5.7, J2 = 7.7, 1H), 3.84 (dd, J1 = 16.3, J2 = 34.8 Hz, 
2H), 3.65 (s, 3H), 3.33 (d, J = 5.7, 2H). 
13
C NMR (150 MHz, CDCl3): δ 193.7, 172.2, 165.9, 163.4, 136.2, 136.1, 131.2, 129.5, 128.9, 128.5, 
127.6, 127.6, 123.1, 122.3, 119.7, 118.7, 115.0, 111.3, 110.1, 70.4, 53.2, 52.5, 45.4, 27.8. 
IR (ν~ /cm−1): 3318, 2950, 1737, 1646, 1597, 1573, 1509, 1455, 1421, 1321, 1254, 1211, 1167, 1115, 
999, 910, 829. 
HRMS (ESI): calcd. for C28H27N2O5 (M+H)
+ 471.1914; found: 471.1917. 
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2.2 (2R,2a1R,9bR)-Methyl 5-(4-(benzyloxy)phenyl)-3-oxo-2,2a1,3,9b-tetrahydro-
1H-2a,5a-diazacyclopenta[jk]fluorene-2-carboxylate (10) 
 
Phosphorus oxychloride (10.2 mL; 108 mmol; 15 eq) was added dropwise to a solution of β-
ketoamide 9 (3.40 g; 7.27 mmol) in dry dichloromethane (66 mL) and the mixture was stirred at room 
temperature for 22 h. The reaction mixture was diluted with dichloromethane and carefully 
quenched with 5% ammonia solution (300 mL), while cooling in an ice bath. The extract was dried 
over anhydrous Na2SO4, filtered and concentrated in vacuo. After flash chromatography (80 % EtOAc 
in hexanes → 100 % EtOAc), 2.45 g (75 %) of the pure product 10 was isolated, in form of a yellow 
foam. 
 
Rf = 0.70 (80% EtOAc in hexanes). 
[α]D
26 = −248.7° (c = 0.79, CHCl3).  
1
H NMR (600 MHz, CDCl3): δ 7.63 (d, J = 8.8, 2H), 7.46 (d, J = 7.3, 2H), 7.42 (t, J = 7.5, 2H), 7.36 (t, J = 
7.3, 1H), 7.19 (d, J = 6.3, 1H), 7.06 (d, J = 8.8, 2H), 6.92 – 6.87 (m, 2H), 6.02 (d, J = 7.4, 1H), 5.93 (d, J = 
7.2, 1H), 5.84 (s, 1H), 5.14 (s, 2H), 4.48 (dd, J1 = 5.8, J2 = 8.7, 1H), 4.20 (td, J1 = 3.6, J2 = 8.1, 1H), 3.80 
(s, 3H), 2.64 (ddd, J1 = 5.7, J2 = 8.7, J3 = 14.3, 1H), 2.58 – 2.52 (m, 1H). 
13
C NMR (150 MHz, CDCl3): δ 172.5, 162.6, 161.4, 152.1, 145.9, 136.5, 133.3, 130.1, 128.8, 128.5, 
128.4, 127.7, 126.8, 124.9, 122.2, 115.4, 112.8, 105.8, 80.2, 70.4, 56.8, 52.7, 44.8, 35.5. 
IR (ν~ /cm−1): 3008, 2952, 1738, 1642,1506, 1477, 1427, 1369, 1296, 1240, 1218, 1202, 1171, 1113, 
1023, 1007, 826. 
HRMS (ESI): calcd. for C28H25N2O4 [M+H]
+ 453.1809; found: 453.1814. 
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2.3 (2R,2a
1
R,9bR)-methyl 5-(4-((4-nitrobenzoyl)oxy)phenyl)-3-oxo-2,2a
1
,3,9b-
tetrahydro-1H-2a,5a-diazacyclopenta[jk]fluorene-2-carboxylate (15) 
 
10% Palladium on charcoal (20.0 mg) was added to a solution of tetracyclic compound 10 (100 mg; 
0.220 mmol) in methanol (3 mL), and the mixture was stirred for 2 h under 1 atm of hydrogen. The 
mixture was filtered through a plug of celite and the solvent was removed in vacuo, to yield 78.0 mg 
(94%) of the virtually pure phenol, as a colorless oil. 
p-Nitrobenzoyl chloride (42.0 mg; 0.228 mmol; 1.1 eq) was added to a solution of phenol  (75.0 mg; 
0.207 mmol) and triethylamine (38.0 µL; 0.269 mmol; 1.3 eq) in dichloromethane (3 mL), and the 
solution was stirred for 5 minutes. The reaction mixture was diluted with dichloromethane, washed 
with 1M HCl and brine and the organic extract was dried over anhydrous Na2SO4. The drying agent 
was filtered off and the filtrate was concentrated in vacuo, to give a yellowish-white solid (59.0 mg; 
79%). The crude ester 15 was recrystallized from methanol and crystals suitable for X-ray analysis 
were obtained. 
 
Rf = 0.20 (60% EtOAc in hexanes). 
[α]D
22 = −320.9 ° (c = 0.24, CHCl3). 
m.p.: 192 – 194 °C (MeOH).  
1H NMR (400 MHz, CDCl3): δ 8.40 (d, J = 1.9, 4H), 7.80 (d, J = 8.7, 2H), 7.38 (d, J = 8.7, 2H), 7.22 (d, J = 
6.6, 1H), 7.00 – 6.88 (m, 2H), 6.07 – 6.01 (m, 1H), 6.00 – 5.94 (m, 2H), 4.51 (dd, J1 = 8.7, J2 = 5.8, 1H), 
4.23 (t, J = 5.9, 1H), 3.81 (s, 3H), 2.73 – 2.51 (m, 2H). 
13C NMR (100 MHz, CDCl3): δ 172.4, 163.1, 162.2, 152.7, 151.2, 151.2, 145.6, 134.6, 133.3, 132.3, 
131.5, 129.9, 128.7, 125.1, 124.0, 122.5, 122.4, 112.7, 107.8, 80.3, 56.8, 52.8, 44.8, 35.5. 
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IR ( /cm
−1
): 2948, 2357, 1736, 1723, 1652, 1600, 1524, 1504, 1477, 1460, 1423, 1406, 1345, 1321, 
1292, 1266, 1209, 1166, 1108, 1083, 1027. 
HRMS (ESI): calcd. for C28H21O7N3Na [M+Na]
+ 534.1272; found 534.1272. 
 
2.4 (2a
1
R,9bR)-Methyl 5-(4-(benzyloxy)phenyl)-3-oxo-3,9b-dihydro-2a
1
H-2a,5a-
diazacyclopenta[jk] fluorene-2-carboxylate (11) 
 
n-Butyl lithium (1.6 M; 11.0 mL; 17.7 mmol; 2 eq) was added to a cold (-30 °C) solution of 
hexamethyldisilazane (3.9 mL; 18.6 mmol; 2.2 eq) in dry THF (50 mL) and the mixture was stirred at 0 
°C for 30 minutes. The resulting solution of LiHMDS was added to a cold (-60 °C) solution of ester 10 
(4.00 g; 8.85 mmol) in dry THF (100 mL). After 20 minutes of stirring, a solution of PhSeBr (4.59 g; 
19.5 mmol; 2.2 eq) in THF (50 mL) was added and the mixture was stirred for additional 20 minutes. 
The reaction mixture was diluted with ethyl acetate and washed with saturated NH4Cl and brine, 
dried over anhydrous MgSO4, filtered and concentrated in vacuo. The crude mixture was dissolved in 
dichloromethane (50 mL), and treated with mCPBA (77%; 2.58 g; 11.5 mmol; 1.3 eq) at 0 °C. After 15 
minutes, the mixture was washed with 5% sodium thiosulfate, saturated NaHCO3 and brine, the 
organic extract was dried over anhydrous MgSO4 and filtered. The solvent was removed in vacuo, 
and the residue was purified by flash chromatography (50% EtOAc in hexanes) to yield 2.45 g (62%) 
of the unsaturated ester 11, as a yellow foam. 
Rf = 0.30 (20% Et2O in DCM). 
[α]D
24 = −397.8 ° (c = 0.45, CHCl3). 
1
H NMR (600 MHz, CDCl3): δ 7.64 (d, J = 8.9, 2H), 7.47 – 7.46 (m, 2H), 7.43 – 7.41 (m, 2H), 7.37 – 7.36 
(m, 1H), 7.25 – 7.20 (m, 1H), 7.07 (d, J = 8.9, 2H), 6.94 – 6.89 (m, 2H), 6.15 – 6.10 (m, 1H), 6.00 (d, J = 
3.6, 1H), 5.94 (d, J = 9.8, 1H), 5.91 (s, 1H), 5.15 (s, 2H), 4.61 (dd, J1 = 9.8, J1 = 3.6, 1H), 3.88 (s, 3H). 
13C NMR (150 MHz, CDCl3): δ 162.3, 161.6, 160.1, 151.8, 145.2, 137.1, 136.4, 130.3, 128.8, 128.5, 
128.4, 127.7, 127.2, 126.4, 125.2, 122.6, 116.1, 115.6, 112.5, 105.8, 80.2, 70.4, 52.9, 48.4. 
IR (ν~ /cm−1): 2922, 1736, 1649, 1600, 1505, 1476, 1459, 1423, 1409, 1360, 1287, 1244, 1227, 1171, 
1120, 1020, 1000, 907, 819.  
HRMS (ESI): calcd. for C28H23N2O4 [M+H]
+ 451.1652; found: 451.1661. 
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2.5 (1S,2R,2a
1
R,9bR)-Methyl 5-(4-(benzyloxy)phenyl)-1-hydroxy-3-oxo-2,2a
1
,3,9b-
tetrahydro-1H-2a,5a-diazacyclopenta[jk]fluorene-2-carboxylate (12) 
 
Bis(pinacolato)diboron (1.40 g; 5.52 mmol; 1.2 eq) was added to a solution of chloro[1,3-bis(2,4,6-
trimethylphenyl)imidazol-2-ylidene]copper(I) (223 mg; 12 mol%) and t-BuONa (79.6 mg; 18 mol%) in 
dry THF (10 mL), under nitrogen. After 5 minutes, a solution of unsaturated ester 11 (2.07 g; 4.60 
mmol) in dry THF (32 mL) was added, followed by methanol (240 µL; 5.98 mmol; 1.3 eq). After 40 
minutes, a solution of sodium perborate tetrahydrate (1.42 g; 9.20 mmol; 2 eq) in water (20 mL) was 
added and stirring was continued for 30 minutes. The reaction mixture was partitioned between 
ether and brine, and the organic extract was dried over anhydrous Na2SO4. After filtration, the 
solvent was removed in vacuo and the residue was purified by flash chromatography (80% EtOAc in 
hexanes), to afford 1.57 g (73%) of the pure alcohol 12, as a pale yellow foam. 
 
Rf = 0.30 (80% EtOAc in hexanes). 
[α]D
24 = −209.7 ° (c = 0.33, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 7.61 (d, J = 8.8, 2H), 7.51 – 7.29 (m, 6H), 7.05 (d, J = 8.8, 2H), 6.98 – 6.83 
(m, 2H), 6.11 (d, J = 7.2, 1H), 6.02 (d, J = 8.5, 1H), 5.84 (s, 1H), 5.13 (s, 2H), 4.74 (dd, J1 = 6.8, J2 = 2.7 
Hz, 1H), 4.61 (d, J = 6.8, 1H), 4.12 (d, J = 7.2, 1H), 3.79 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 169.7, 163.2, 161.4, 152.5, 145.9, 136.4, 130.7, 130.1, 128.8, 128.8, 
128.4, 127.7, 126.4, 125.2, 122.2, 115.4, 112.9, 105.4, 79.2, 77.5, 70.3, 62.8, 54.5, 52.6. 
IR (ν~ /cm−1): 3339, 2975, 1741, 1626, 1601, 1506, 1477, 1433, 1368, 1299, 1248, 1170, 1114, 1076, 
1005. 
HRMS (ESI): calcd. for C28H25N2O5 [M+H]
+ 469.1758; found: 469.1758. 
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2.6 (1S,2S,2a
1
R,9bR)-Methyl 5-(4-(benzyloxy)phenyl)-1-hydroxy-3-oxo-2,2a
1
,3,9b-
tetrahydro-1H-2a,5a-diazacyclopenta[jk]fluorene-2-carboxylate (13) 
 
A solution of ester 12 (2.00 g; 4.27 mmol) and DBU (3.2 mL; 21.4 mmol; 5 eq) in dry methanol (20 
mL) was heated at 70 °C for 2 h, under nitrogen. The reaction mixture was cooled to room 
temperature and quenched by addition of 1M HCl (to pH=5). The reaction mixture was extracted with 
ethyl acetate, the organic layer was washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. The residual mixture of diastereomeric esters (ca. 1:1) was purified by flash 
chromatography (100% EtOAc), to afford separated diastereomeric esters. The total of 1.46 g (73%) 
of ester 13 was obtained through two isomerisation cycles as a colorless foam. 
 
Rf = 0.30 (100% EtOAc).  
[α]D
24 = −86.7 ° (c = 0.24, MeOH).  
1H NMR (400 MHz, CDCl3): δ 7.70 (d, J = 8.8, 2H), 7.47 – 7.36 (m, 5H), 7.17 (d, J = 7.4, 1H), 7.07 (d, J = 
8.8, 2H), 6.91 (t, J = 7.7, 1H), 6.82 (t, J = 7.4, 1H), 6.08 (d, J = 8.0, 1H), 5.96 (s, 1H), 5.91 (d, J = 6.7, 1H), 
5.15 (s, 2H), 4.86 (d, J = 4.3, 1H), 4.71 (s, 1H), 4.15 (d, J = 6.7, 1H), 3.15 (s, 3H), 3.07 (d, J = 4.6, 1H). 
13
C NMR (100 MHz, CDCl3): δ 168.7, 164.9, 161.6, 153.6, 147.4, 136.5, 130.4, 129.4, 129.1, 128.8, 
128.4, 127.7, 126.6, 125.1, 121.9, 115.5, 112.8, 106.4, 80.5, 80.1, 70.4, 68.6, 53.6, 52.4. 
IR (ν~ /cm−1): 3262, 2933, 1733, 1625, 1600, 1504, 1475, 1428, 1333, 1300, 1247, 1171, 1009, 821. 
HRMS (ESI): calcd. for C28H25N2O5 [M+H]
+ 469.1758; found: 469.1758. 
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2.7 (1S,2S,2a
1
R,9bR)-Methyl 5-(4-(benzyloxy)phenyl)-1-((tert-
butyldimethylsilyl)oxy)-3-oxo-2,2a
1
,3,9b-tetrahydro-1H-2a,5a-
diazacyclopenta[jk]fluorene-2-carboxylate (14) 
 
TBDMSOTf (668 μL; 2.91 mmol; 1.5 eq) was added dropwise to a solution of alcohol 13 (0.910 g; 1.94 
mmol) and 2,6-lutidine (550 μL; 4.85 mmol; 2.5 eq) in dry dichloromethane (3 mL). After 45 minutes 
of stirring, the reaction mixture was diluted with dichloromethane, washed with saturated NaHCO3 
and brine, dried over anhydrous MgSO4, filtered and concentrated in vacuo. The residue was purified 
by flash chromatography (100% EtOAc) to yield 1.10 g (97%) of the TBDMS-protected product 14, as 
a colorless oil. 
 
Rf = 0.30 (50% EtOAc in hexanes).  
[α]D
24 = −185.8 ° (c = 0.30, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 7.69 (d, J = 8.9, 2H), 7.48 – 7.34 (m, 5H), 7.11 (d, J = 7.4, 1H), 7.07 (d, J = 
8.9, 2H), 6.91 (t, J = 7.7, 1H), 6.81 (t, J = 7.4, 1H), 6.08 (d, J = 8.0, 1H), 5.96 (s, 1H), 5.91 (d, J = 6.7, 1H), 
5.15 (s, 2H), 4.77 (s, 1H), 4.59 (s, 1H), 4.01 (d, J = 6.7, 1H), 3.18 (s, 3H), 0.98 (s, 9H), 0.26 (s, 3H), 0.24 
(s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 168.9, 164.4, 161.5, 153.1, 147.4, 136.5, 130.3, 129.6 , 129.0, 128.8, 
128.4, 127.7, 126.8, 124.8, 121.7, 115.4, 112.8, 106.7, 81.0, 80.6, 70.4, 68.7, 54.8, 52.2, 25.9, 18.3, -
4.6, -4.8. 
IR (ν~ /cm−1): 2951, 2927, 2360, 1757, 1736, 1644, 1602, 1505, 1476, 1460, 1423, 1409, 1300, 1250, 
1171, 1081. 
HRMS (ESI): calcd. for C34H39N2O5Si [M+H]
+ 583.2623; found: 583.2620. 
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2.8 (1S,2S,2a
1
R,9bR)-Methyl 4-amino-1-((tert-butyldimethylsilyl)oxy)-5-(4-
hydroxyphenyl)-3-oxo-2,2a
1
,3,9b-tetrahydro-1H-2a,5a-
diazacyclopenta[jk]fluorene-2-carboxylate (18) 
 
Copper(II) trifluoromethanesulfonate (342 mg; 50 mol%) was added to a solution of tetracycle 14 
(1.10 g; 1.89 mmol) and dibenzyl azodicarboxylate (880 mg; 2.83 mmol; 1.5 eq) in dry 
dichloromethane (25 mL). The reaction mixture was stirred at room temperature for 4 h and the 
mixture was partitioned between ether and water and the organic layer was washed with 5% 
ammonia solution and brine. The organic extract was dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. The crude material was purified by flash chromatography (30% 
EtOAc/hexanes), to afford 1.42 g (86%) of the pure product, as a yellowish foam. 
10% palladium on charcoal (450 mg) was added to a solution of hydrazine 16 (1.05 g; 1.19 mmol) in 
methanol (35 mL) and the reaction mixture was stirred under hydrogen (balloon pressure) for 1 h. 
The reaction mixture was filtered through a pad of celite, the celite was washed with methanol and 
the filtrate was concentrated. The residue was purified by flash chromatography (60% EtOAc in 
hexanes), to afford 545 mg (90%) of the pure amine 18, as a yellowish oil. 
 
Rf = 0.50 (80% EtOAc in hexane). 
[α]D
24 = −246.7° (c = 0.33, MeOH). 
1H NMR (400 MHz, CD3OD): δ 7.65 (d, J = 8.8, 2H), 7.10 (d, J = 7.4, 1H), 6.91 (d, J = 8.8, 2H), 6.86 (t, J = 
7.7, 1H), 6.74 (t, J = 7.9, 1H), 5.90 (d, J = 8.0, 1H), 5.80 (d, J = 6.2, 1H), 4.88 (s, 1H), 4.51 (s, 1H), 3.99 
(d, J = 6.2, 1H), 3.70 (s, 2H), 3.17 (s, 3H), 1.01 (s, 9H), 0.30 (s, 3H), 0.28 (s, 3H). 
13C NMR (100 MHz, CD3OD): δ 169.5, 164.1, 159.5, 150.3, 131.6, 129.8, 129.8, 128.2, 126.6, 125.5, 
125.3, 121.9, 117.0, 113.3, 81.9, 80.9, 70.0, 55.7, 52.7, 26.2, 19.0, -4.7, -4.8. 
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IR (ν~ /cm−1): 3301, 2949, 2855, 1736, 1639, 1602, 1511, 1476, 1459, 1434, 1360, 1300, 1260, 1168, 
1088. 
HRMS (ESI): calcd. for C27H34N3O5Si [M+H]
+ 508.2262; found: 508.2260. 
 
2.9 (2R,2a
1
R,9bR)-Methyl 4-amino-1-((tert-butyldimethylsilyl)oxy) 5-(4-((4-
nitrobenzoyl)oxy)phenyl)-3-oxo-2,2a
1
,3,9b-tetrahydro-1H-2a,5a-
diazacyclopenta[jk]fluorene-2-carboxylate (23) 
 
p-Nitrobenzoyl chloride (18.2 mg; 0.098 mmol; 1.1 eq) was added to a solution of phenol 18 (45 mg; 
0.0891 mmol) and triethylamine (16.0 µL; 0.116 mmol; 1.3 eq) in dichloromethane (2 mL), and the 
solution was stirred for 5 minutes. The reaction mixture was diluted with dichloromethane, washed 
with brine, and the organic extract was dried over anhydrous Na2SO4. The drying agent was filtered 
off and the filtrate was concentrated in vacuo, to give a red solid (33.0 mg; 56%). The crude ester 23 
was recrystallized from methanol and red crystals suitable for X-ray analysis were obtained. 
 
Rf = 0.20 (30% EtOAc in hexanes). 
1H NMR (400 MHz, CD3OD): δ 8.14 – 8.12 (m, 2H), 8.03 (d, J = 8.9, 1H), 7.74 (d, J = 8.7, 2H), 7.46 (dd, J 
= 12.9, 8.7, 1H), 7.22 (d, J = 8.8, 2H), 6.93 (d, J = 7.4, 1H), 6.69 (t, J = 7.2, 1H), 6.57 (t, J = 7.2, 1H), 5.76 
(d, J = 7.9, 1H), 5.66 (d, J = 6.1, 1H), 4.70 (s, 1H), 4.31 (s, 1H), 3.81 (d, J = 6.1, 1H), 3.76 (s, 1H), 2.99 (s, 
3H), 0.80 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H). 
13C NMR (101 MHz, CD3OD): δ 167.46, 165.54 (HMBC), 163.80 (HMBC), 160.95 (HMBC), 157.53, 
149.92, 148.33, 135.79 (HMBC), 133.45, 133.27 (HMBC), 130.45, 129.79, 129.66, 127.99, 122.90, 
122.69, 119.91, 115.05, 111.35, 79.90, 78.87, 68.05, 53.70, 50.70, 24.24, 17.00, -6.72, -6.80. 
IR (ν~ /cm−1): 2948, 2929, 1729, 1650, 1599, 1523, 1457, 1429, 1347, 1260, 1194, 1157, 1081, 1011. 
HRMS (ESI): calcd. for C34H37N4O8Si [M+H]+ 657.2375; found 657.2373. 
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2.10 (1S,2S,2a
1
R,9bR)-Methyl 4-amino-5-(4-(benzyloxy)phenyl)-1-((tert-
butyldimethylsilyl)oxy)-3-oxo-2,2a
1
,3,9b-tetrahydro-1H-2a,5a-
diazacyclopenta[jk]fluorene-2-carboxylate (18) 
 
To a solution of phenol 17 (545 mg; 1.07 mmol) in dry DMF were added Cs2CO3 (523 mg; 1.60 mmol; 
1.5 eq), benzyl bromide (140 µL; 1.18 mmol; 1.1 eq) and TBAI (80.0 mg; 20 mol%). The reaction 
mixture was stirred at room temperature for 30 minutes. The mixture was diluted with ether, 
washed with water and brine, dried over anhydrous MgSO4, filtered and concentrated in vacuo. The 
crude product was purified by flash chromatography, to yield (428 mg; 67%) of benzyl ether 18, as a 
yellowish foam. 
 
Rf = 0.30 (30% EtOAc in hexanes). 
[α]D
23 = −166.9° (c = 0.35, MeOH).  
1H NMR (400 MHz, CD3OD): δ 7.75 (d, J = 8.9, 2H), 7.47 (d, J = 8.5, 2H), 7.39 (t, J = 7.9, 2H), 7.35 – 
7.30 (m, 1H), 7.14 – 7.10 (m, 3H), 6.85 (t, J = 7.7, 1H), 6.75 (t, J = 7.8, 1H), 5.88 (d, J = 7.9, 1H), 5.81 (d, 
J = 6.2, 1H), 5.16 (s, 2H), 4.89 (s, 1H), 4.51 (s, 1H), 3.99 (d, J = 6.2, 1H), 3.66 (s, 1H) 3.17 (s, 3H), 1.01 (s, 
9H), 0.30 (s, 3H), 0.28 (s, 3H). 
13
C NMR (100 MHz, CD3OD): δ 169.4, 164.0, 160.6, 150.3, 138.4, 131.5, 129.8, 129.7, 129.6, 129.0, 
128.7, 128.3, 127.2, 126.1, 125.5, 121.9, 116.6, 113.2, 81.9, 80.9, 71.1, 70.0, 55.7, 52.7, 26.2, 19.0, -
4.7, -4.8. 
IR (ν~ /cm−1): 3357, 2950, 2925, 2853, 1758, 1731, 1656, 1601, 1573, 1507, 1475, 1459, 1432, 1361, 
1299, 1245, 1222, 1169, 1086, 1005. 
HRMS (ESI): calcd. for C34H40N3O5Si [M+H]+ 598.2732; found 598.2726. 
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2.11 (1S,2S,2a
1
R,4S,5R,9bR)-Methyl 4-amino-5-(4-(benzyloxy)phenyl)-1-((tert-
butyldimethylsilyl)oxy)-3-oxo-2,2a
1
,3,4,5,9b-hexahydro-1H-2a,5a-
diazacyclopenta[jk]fluorene-2-carboxylate (19) 
 
A solution of enamine 18 (100 mg; 0.168 mmol) in trifluoroethanol (5 mL) was degassed with argon 
and (±)-1,2-bis(2,5-diethylphospholano)benzene)1,5-cyclooctadiene)rhodium(I) tetrafluoroborate 
(11.1 mg; 10 mol%) was added. After additional 5 minutes of argon bubbling, the mixture was 
transferred in a high pressure autoclave. The reaction mixture was stirred for 10 h under hydrogen 
(125 bar), at 50 °C. The solvent was removed on rotovap and the residue was purified by column 
chromatography (100% EtOAc → 5% MeOH in EtOAc), to give 98.0 mg (97%) of amine 19, as a 
colorless oil. 
 
Rf = 0.10 (100% EtOAc).  
[α]D
23 = 79.0° (c = 0.20, MeOH). 
1H NMR (500 MHz, CD3OD): δ 7.42 (d, J = 8.8, 2H), 7.36 (t, J = 7.8, 2H), 7.32 – 7.26 (m, 3H), 7.10 (d, J = 
7.4, 1H), 6.92 (d, J = 7.8, 2H), 6.71 (t, J = 7.5, 1H), 6.57 (t, J = 7.8, 1H), 5.90 (d, J = 8.3, 1H), 5.47 (d, J = 
8.0, 1H), 5.11 (d, J = 7.4, 1H), 5.06 (s, 2H), 4.76 – 4.73 (m, 1H), 4.28 (d, J = 4.3, 1H), 4.23 (d, J = 7.4, 
1H), 3.82 (dd, J1 = 8.2, J2 = 3.3, 1H), 3.66 (s, 3H), 0.99 (s, 9H), 0.22 (s, 3H), 0.15 (s, 3H). 
13C NMR (125 MHz, CD3OD): δ 171.5, 170.5, 160.4, 149.1, 138.6, 129.6, 129.5, 129.0, 128.9, 128.6, 
128.0, 127.6, 125.1, 118.9, 115.8, 112.2, 84.5, 78.1, 71.0, 68.4, 63.3, 56.5, 55.9, 53.0, 26.2, 18.8, -4.5, 
-4.6. 
IR (ν~ /cm−1): 3360, 3033, 2953, 2930, 2857, 1746, 1687, 1606, 1510, 1481, 1463, 1431, 1363, 1251, 
1174, 1090, 1022. 
HRMS (ESI): calcd. for C34H42N3O5Si [M+H]+ 600.2888; found 600.2889. 
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2.12 (1S,2S,2a
1
R,4S,5R,9bR)-Methyl 4-((2S,3S)-2-
(((benzyloxy)carbonyl)(methyl)amino)-3-methylpentan amido)-5-(4-
(benzyloxy)phenyl)-1-((tert-butyldimethylsilyl)oxy)-3-oxo-2,2a
1
,3,4,5,9b-
hexahydro-1H-2a,5a-diazacyclopenta[jk]fluorene-2-carboxylate (20) 
 
N-methymorpholine (150 µL; 1.33 mmol; 3 eq) was added to a solution of amine 19 (267 mg; 0.445 
mmol), Cbz-N-Me-Ile-OH (162 mg; 0.579 mmol; 1.3 eq) and BOP (315 mg; 0.712 mmol; 1.6 eq) in dry 
dichloromethane (5 mL) and the mixture was stirred at room temperature for 3 h. The mixture was 
diluted with ether, washed with 1M HCl, saturated NaHCO3 and brine. The organic layer was dried 
over anhydrous MgSO4, filtered and concentrated. The residue was purified by column 
chromatography (20% EtOAc in hexanes), to afford 379 mg (99%) of the peptide 20, as a colorless 
viscous oil. 
 
Rf = 0.30 (40% EtOAc in hexanes).  
[α]D
23 = 113.3° (c = 0.10, MeOH). 
1
H NMR (500 MHz, DMSO-d6, 333 K): δ 7.44 – 7.18 (m, 10H), 7.11 (d, J = 7.4, 1H), 7.04 (d, J = 8.8, 2H), 
6.81 (d, J = 8.7, 2H), 6.73 (t, J = 7.6, 1H), 6.61 – 6.49 (m, 2H), 6.01 (d, J = 8.6, 1H), 5.47 (d, J = 7.9, 1H), 
5.31 (d, J = 7.5, 1H), 5.23 (t, J = 7.0, 1H), 5.10 – 4.89 (m, 4H), 4.68 – 4.62 (m, 1H), 4.19 (d, J = 5.0, 1H), 
4.16 (d, J = 10.9, 1H), 3.83 (dd, J1 = 8.5, J2 = 3.8 Hz, 1H), 3.64 (s, 3H), 2.82 (s, 3H), 2.04 – 1.90 (m, 1H), 
1.38 – 1.14 (m, 2H), 0.96 (s, 9H), 0.84 – 0.73 (m, 6H), 0.18 (s, 3H), 0.11 (s, 3H). 
13C NMR (125 MHz, DMSO-d6, 333 K): δ 168.8, 168.4, 164.6, 158.0, 155.6, 147.2, 136.8, 136.5, 130.1, 
128.0, 127.5, 127.4, 127.3, 127.2, 126.8, 126.8, 126.4, 123.7, 117.2, 114.1, 109.9, 83.0, 75.8, 69.1, 
66.2, 66.2, 61.8, 58.0, 53.6, 53.0, 51.9, 31.4, 29.4, 25.3, 23.9, 17.3, 14.9, 9.7, -5.0, -5.2. 
IR (ν~ /cm−1): 3398, 3060, 3033, 2956, 2931, 2892, 2858, 1748, 1698, 1607, 1511, 1481, 1435, 1366, 
1306, 1250. 
HRMS (ESI): calcd. for C49H61N4O8Si [M+H]+ 861.4253; found 861.4261. 
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2.13 (1S,2S,2a
1
R,4S,5R,9bR)-Methyl 4-((2S,3S)-2-
(((benzyloxy)carbonyl)(methyl)amino)-3-methylpentan amido)-5-(4-
(benzyloxy)phenyl)-1-hydroxy-3-oxo-2,2a
1
,3,4,5,9b-hexahydro-1H-2a,5a-
diazacyclopenta[jk]fluorene-2-carboxylate (21) 
 
50% HF (1.5 mL) was added to a solution of peptide 20 (380 mg; 0.441 mmol) in MeCN (4 mL) in a 
polyethylene vessel, and the reaction mixture was stirred 1h at 45 °C. The reaction mixture was 
diluted with ether, washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered 
and concentrated in vacuo. The crude product was purified by column chromatography (50% EtOAc 
in hexanes), to afford 292 mg (87%) of alcohol 21, as a colorless oil. 
 
Rf = 0.30 (50% EtOAc in hexanes).  
[α]D
23 = 149.2° (c = 0.50, MeOH). 
1H NMR (500 MHz, DMSO-d6, 333 K): δ 7.44 – 7.23 (m, 10H), 7.17 (d, J = 7.2, 1H), 7.05 (d, J = 8.6, 2H), 
6.80 (d, J = 8.5, 2H), 6.71 (t, J = 7.6, 1H), 6.54 (t, J = 7.3, 2H), 6.20 (d, J = 5.3, 1H), 5.97 (d, J = 8.6, 1H), 
5.47 (d, J = 7.5, 1H), 5.32 (d, J = 7.3, 1H), 5.21 (t, J = 6.8, 1H), 4.99 (s, 3H), 4.50 (d, J = 4.7, 1H), 4.16 (d, 
J = 5.5, 2H), 3.78 (dd, J1 = 8.4, J2 = 4.3, 1H), 3.63 (s, 3H), 2.83 (s, 3H), 1.98 (br s, 1H), 1.35 – 1.27 (m, 
1H), 1.00 – 0.91 (m, 1H), 0.86 – 0.75 (m, 6H). 
13
C NMR (125 MHz, DMSO-d6, 333 K): δ 168.9, 168.6, 164.5, 157.9, 155.4 (detected by HMBC), 146.9, 
136.8, 136.5, 130.1, 128.0 (2 signals), 127.8, 127.4, 127.3, 127.2, 126.8 (2 signals), 126.5, 123.8, 
117.1, 114.0, 109.6, 82.0, 75.7, 69.1, 66.2, 65.5, 61.8, 58.0, 53.0, 52.9, 51.8, 31.5, 29.4, 23.9, 14.9, 
9.7. 
IR (ν~ /cm−1): 3395, 2962, 1748, 1692, 1671, 1607, 1512, 1480, 1439, 1401, 1370, 1308, 1242, 1175, 
1114. 
HRMS (ESI): calcd. for C43H46N4O8Si [M+Na]
+ 769.3208; found 769.3189. 
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2.14 (1S,2S,2a
1
R,4S,5R,9bR)-4-((2S,3S)-2-(((Benzyloxy)carbonyl)(methyl)amino)-3-
methylpentanamido)-5-(4-(benzyloxy)phenyl)-1-(carbamoyloxy)-3-oxo-
2,2a
1
,3,4,5,9b-hexahydro-1H-2a,5a-diazacyclopenta[jk]fluorene-2-carboxylic 
acid (22) 
 
A solution of NaOH (13.4 mg/1 mL H2O; 0.335 mmol; 2.5 eq) was added to methylester 21 (100 mg; 
0.134 mmol), dissolved in CaCl2 solution (0.8 M CaCl2 in i-PrOH/H2O 7:3; 10 mL). The mixture was 
stirred for 4 h, before it was acidified with 1M HCl solution and extracted with EtOAc (50 mL). The 
organic layer was washed with brine, dried over MgSO4 and concentrated, to give free acid as a 
colorless solid (90.5 mg; 92%). The crude acid was dissolved in CH2Cl2 (6 mL), 
chlorosulfonylisocyanate (21.5 µL; 0.250 mmol) was added and the mixture was stirred for 15 min at 
room temperature. THF (10 mL) and H2O (10 mL) were added and the mixture was stirred for 10 min 
at room temperature. The product was extracted with EtOAc (10 mL), washed with brine, dried over 
MgSO4 and concentrated. The residue was purified by three column chromatographies (1. 0.4 % 
formic acid in EtOAc; 2. 100 % EtOAc→ 0.4 % formic acid in EtOAc; 3. 50% EtOAc in hexanes → 0.4 % 
formic acid in EtOAc), to yield 62 mg (65%) of carbamate 22, as a white solid. 
 
[α]D
23 = 95.6° (c = 0.52, MeOH). 
1H NMR (500 MHz, DMSO-d6, 333 K): δ 7.41 – 7.22 (m, 10H), 7.24 (d, J = 7.2, 1H), 7.17 (d, J = 8.5, 2H), 
6.75 (d, J = 7.4, 2H), 6.68 (t, J = 7.7, 1H), 6.55 (t, J = 7.2, 1H), 6.48 (d, J = 5.8, 1H), 5.99 (d, J = 8.5, 1H), 
5.46 – 5.32 (m, 3H), 5.27 (t, J = 6.9, 1H), 5.01 – 4.96 (m, 4H), 4.28 (d, J = 3.9, 1H), 4.14 (d, J = 10.3, 1H), 
3.98 (d, J = 8.3, 1H), 2.80 (s, 3H), 1.98 – 1.94 (m, 1H), 1.33 – 1.26 (m, 1H), 0.96 – 0.92 (m, 1H), 0.82 – 
0.76 (m, 6H). 
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13C NMR (125 MHz, DMSO, 333 K): δ 168.9, 168.8, 164.8, 157.9, 156.8, 155.2, 147.6, 136.8, 136.5, 
130.6, 128.0, 128.0, 127.4, 127.4, 127.2, 127.2, 126.8, 126.2, 126.0, 124.5, 117.5, 113.9, 110.5, 81.8, 
75.8, 69.1, 66.2, 64.1, 61.9, 58.6, 53.2, 51.7, 31.4, 29.4, 23.9, 14.9, 9.7. 
IR (ν~ /cm−1): 3394, 3193, 3063, 3034, 2964, 2931, 2878, 2502, 2257, 2127, 1736, 1693, 1607, 1512, 
1480, 1441, 1390, 1311, 1244, 1180, 1154. 
HRMS (ESI): calcd. for C43H45N5O9Na [M+Na]
+ 798.3109; found 798.3093. 
 
2.15 (1S,2S,2a
1
R,4S,5R,9bR)-1-(Carbamoyloxy)-5-(4-hydroxyphenyl)-4-((2S,3S)-3-
methyl-2-(methylamino)pentanamido)-3-oxo-2,2a
1
,3,4,5,9b-hexahydro-1H-
2a,5a-diazacyclopenta [jk]fluorene-2-carboxylic acid (Crocagin A, 1) 
 
10 % palladium on charcoal (16.5 mg) was added to a solution of benzylether 22 (30.0 mg; 0.0387 
mmol) in methanol (3 mL) and the mixture was stirred for 1.5 h under 1 atm of hydrogen. The 
mixture was diluted with EtOAc (15 mL) and filtered through a pad of celite. The filtrate was 
evaporated to dryness, to afford 18.2 mg (87%) of crocagin A (1) in a virtually pure form (white 
amorphous solid). 
 
[α]D
24 = +93.6° (c = 0.16, MeOH).1 
1
H NMR (700 MHz, DMSO-d6)*: δ 9.30 (br s, 1H, phenolic OH), 8.04 
(br s, 1H, NHMe), 7.24 (d, J = 6.7, 1H, NHCO), 7.18 (d, J = 7.3, 1H, H-
7), 6.96 (br s, 2H, CONH2), 6.58 (br s, 2H, H-18/20), 6.56 (t, J = 7.3, 
1H, H-9), 6.46 (br s, 2H, H-17/21), 6.44 (t, J = 7.5, 1H, H-8), 5.82 (d, J 
= 8.3, 1H, H-5), 5.26 (s, 1H, H-3), 5.23 (d, J = 8.1, 1H, H-10), 5.09 (d, J 
                                                            
1
 The previously reported optical rotation value of the isolated crocagin A (K. Viehrig, F. Surup, C. Volz, J. 
Herrmann, A. A. Fayad, S. Adam, J. Köhnke, D. Trauner, R. Müller, Angew. Chem. Int. Ed. 2017, 56, 7407-7410.) 
turned out to be incorrect, due to minor impurities present in the isolated material. After thorough purification 
of the natural sample, [α]D
24
 is +92.3° (c = 0.27, MeOH). 
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= 7.8, 1H, H-15), 5.06 (t, J = 6.9, 1H, H-14), 4.03 (s, 1H, H-2), 3.7 (d, J = 7.7, 1H, H-4), 2.59 (d, J = 5.0, 
1H, H-23), 2.13 (s, 3H, H-28), 1.44 (m, 1H, H-24), 1.20 (m, 1H, H-25), 0.93 (m, 1H, H-25), 0.77 (t, J = 
7.7, 3H, H-26), 0.71 (d, J = 6.9, 3H, H-27). 
13C NMR (175 MHz, DMSO-d6)*: δ 172.4 (C-1), 169.0 (C-22), 164.7 (C-13), 156.7 (C-19), 156.2 (C-12), 
148.6 (C-11), 132.1 (C-17/21), 126.8 (C-9), 126.7 (C-6), 124.9 (C-7), 124.6 (C-16), 116.9 (C-8), 115.7 (C-
18/21), 110.5 (C-10), 83.7 (C-3), 75.9 (C-5), 69.6 (C-23), 67.9 (C-2), 60.4 (C-15), 53.1 (C-14), 52.3 (C-4), 
37.5 (C-24), 35.5 (C-28), 24.3 (C-25), 15.6 (C-27), 11.8 (C-26).  
 
*Some chemical shifts in both 1H and 13C NMR spectra of the synthesized (see spectra on the page 
S34) and natural crocagin A (1) are not exactly the same (see the superposed spectra of the 
synthesized and natural product on the page S35), most probably due to slightly different pH values 
of the two samples (see the superposed spectra of the synthesized crocagin A in neutral, acidic and 
basic conditions on the page S36). However, no new signals (or signal duplication) appear after 
mixing the synthetic sample with natural crocagin A (1) (in 2:1 ratio), proofing that these two samples 
have the identical chemical structures (see the mixed NMR spectra on the page S37). 
 
IR (ν~ /cm−1): 3276, 3179, 2962, 2361, 1717, 1664, 1597, 1516, 1477, 1461, 1386, 1366, 1331, 1270, 
1242, 1180, 1050. 
HRMS (ESI): calcd. for C28H34N5O7 [M+H]+ 552.2453; found 552.2441.  
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3 NMR Spectra 
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Inseparable from EtOAc, even after 2 days under vacuum of 10-3 mbar and coevaporation with toluene.  
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Superposed 1H NMR spectra of 
natural (blue) and synthesized 
(red) crocagin A (1) 
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Superposed 1H NMR spectra 
of the synthesized crocagin A 
(1) under neutral (red), acidic 
(TFA; green) and basic 
(pyridine; blue) conditions 
Superposed 13C NMR spectra 
of the synthesized crocagin A 
(1) under neutral (red), acidic 
(TFA; green) and basic 
(pyridine; blue) conditions 
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1H NMR spectrum of the mixture 
of the synthetic crocagin A (1) 
and natural product 
(synthesized:natural=2:1) 
13C NMR spectrum of the mixture 
of the synthetic c ocagin A (1) and 
natural product 
(synthesized:natural=2:1) 
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4 X-ray Crystallographic Data 
Single-Crystal X-ray Analysis of tetracyclic compound 15  
Crystallographic data for compound 15 are deposited at the Cambridge Crystallographic Data Centre, 
the deposition number: CCDC 1524710 
 
Figure 1 Molecular structure of 15 (one molecule out of asymmetric unit). 
Table 1 Crystallographic data for 15. 
 15 
net formula C28H21N3O7 
Mr/g mol
−1 511.482 
crystal size/mm 0.120 × 0.100 × 0.080 
T/K 173(2) 
radiation 'Mo Kα 
diffractometer 'Bruker D8Venture' 
crystal system orthorhombic 
space group P212121 
a/Å 4.7688(2) 
b/Å 20.4417(11) 
c/Å 24.2942(11) 
 S39
α/° 90 
β/° 90 
γ/° 90 
V/Å3 2368.26(19) 
Z 4 
calc. density/g cm−3 1.43455(12) 
μ/mm−1 0.105 
absorption correction multi-scan 
transmission factor range 0.9231–0.9580 
refls. measured 12832 
Rint 0.0307 
mean σ(I)/I 0.0367 
θ range 3.10–25.38 
observed refls. 3658 
x, y (weighting scheme) 0.0371, 0.4195 
hydrogen refinement constr 
Flack parameter 0.7(9) 
refls in refinement 4290 
parameters 344 
restraints 0 
R(Fobs) 0.0342 
Rw(F
2) 0.0792 
S 1.021 
shift/errormax 0.001 
max electron density/e Å−3 0.188 
min electron density/e Å−3 −0.127 
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Single-Crystal X-ray Analysis of tetracyclic compound 23 
Crystallographic data for compound 23 are deposited at the Cambridge Crystallographic Data Centre, 
the deposition number: CCDC 1524711 
 
 
Figure 2 Molecular structure of 23 (two molecules out of assymetric unit). 
Table 2 Crystallographic data for 23. 
 23 
net formula C34H36N4O8Si 
Mr/g mol
−1 656.757 
crystal size/mm 0.200 × 0.050 × 0.020 
T/K 100(2) 
radiation 'Mo Kα 
diffractometer 'Bruker D8Venture' 
crystal system triclinic 
space group P1 
a/Å 7.0977(6) 
b/Å 12.5914(11) 
c/Å 19.2902(16) 
α/° 76.810(2) 
β/° 86.395(2) 
γ/° 75.068(2) 
V/Å3 1621.8(2) 
 S41
Z 2 
calc. density/g cm−3 1.34491(17) 
μ/mm−1 0.131 
absorption correction multi-scan 
transmission factor range 0.8145–0.9585 
refls. measured 59648 
Rint 0.0717 
mean σ(I)/I 0.0687 
θ range 3.04–26.37 
observed refls. 10470 
x, y (weighting scheme) 0.0407, 0.4337 
hydrogen refinement mixed 
Flack parameter 0.07(9) 
refls in refinement 13003 
parameters 885 
restraints 7 
R(Fobs) 0.0450 
Rw(F
2) 0.0972 
S 1.032 
shift/errormax 0.001 
max electron density/e Å−3 0.492 
min electron density/e Å−3 −0.268 
 
  
 S42
5 Literature 
                                                            
[1] J. Zeng, Y. Tan, J. Ma, M. Leow, D. Tirtorahardjo, X. Liu Chemistry – A European Journal 
2014, 20, 405 – 409.  
